Glide Pharma
45B Milton Park
Abingdon
Oxfordshire
OX14 4RU
United Kingdom
Tel: 44-0-8700-853700
Fax: 44-0-8700-853704
Website: http://www.glidepharma.com/
Email: enquiries@glidepharma.com
14 articles about Glide Pharma
-
Glide Pharma Takes Exclusive Worldwide Rights To Novel Diagnostic Technology For Prostate Cancer
7/29/2014
-
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide
7/22/2014
-
Glide Pharma Appoints Richard Bungay As Chief Financial Officer And Tony Mills As Director Of Business Development
7/8/2014
-
Glide Pharma Appoints Bryan G Morton as Chairman and Announces Board Changes
10/9/2013
-
Glide Pharma Announces Design Optimisation Agreement With Nypro Healthcare for Scale Up of Solid Dose Delivery Device
7/2/2013
-
Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
4/30/2013
-
Glide Pharma Appoints Dr Mark Carnegie-Brown as Chief Executive
3/6/2013
-
Glide Pharma Announces Completion of $21.4 Million Investment
2/26/2013
-
Glide Pharma Announces £2.3 Million ($3.7 Million) Award From UK Biomedical Catalyst for Development of Osteoporosis Treatment
11/5/2012
-
Glide Pharma Completes Oversubscribed $4.3 Million Investment Round
2/10/2010
-
Glide Pharma Secures Further £2.2 Million to Accelerate Development Programme
10/13/2008
-
Glide Pharma Secures £2.3 Million; Distribution Agreement Signed with Paladin Labs Inc.
8/13/2007
-
Paladin Labs Inc. And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
8/10/2007
-
Glide Pharma is Overall Winner of Prestigious 2007 Medical Futures Innovation Awards
6/18/2007